SCHEMBL8882467

SCHEMBL8882467

CC(=O)NCCc1ccc(/C(=C/CCCC(=O)O)c2cccnc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 20/20 0.77
TBXA2R P21731 14/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8882471 1.00 TBXAS1 (0.77) TBXAS1TBXA2R
SCHEMBL8882523 0.97 TBXAS1 (0.73) TBXAS1TBXA2R
SCHEMBL8882531 0.97 TBXAS1 (0.73) TBXAS1TBXA2R
SCHEMBL8884783 0.94 TBXAS1 (0.68) TBXAS1TBXA2R
SCHEMBL8884779 0.94 TBXAS1 (0.68) TBXAS1TBXA2R
SCHEMBL10444949 0.90 TBXAS1 (0.64) TBXAS1TBXA2R
SCHEMBL10444950 0.90 TBXAS1 (0.64) TBXAS1TBXA2R
SCHEMBL8883957 0.84 TBXAS1 (0.76) TBXAS1TBXA2R
SCHEMBL8883953 0.84 TBXAS1 (0.76) TBXAS1TBXA2R
SCHEMBL9002243 0.83 TBXAS1 (0.74) TBXAS1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5681961-A TREATMENT AND/OR PREVENTION OF THROMBOEMBOLIC DISORDERS, ARTERIOSCLEROSIS, METASTASIS. ISCHEMIA, ASTHMA, ALLERGIES DR. KARL THOMAE GMBH (DE) 1997-10-28 US disclosed
EP-0397044-B1 Arylsulfonamides, medicines containing these compounds and process for their preparation THOMAE GMBH DR K (DE) 1995-12-27 EP disclosed
US-5426119-A Thromboxane antagonists DR. KARL THOMAE GMBH (DE) 1995-06-20 US disclosed
US-5294626-A Thromboxane synthesis inhibitors and anticoagulants DR. KARL THOMAS GMBH (DE) 1994-03-15 US disclosed
EP-0397044-A2 Arylsulfonamides, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1990-11-14 EP disclosed